Dialysis world news


Saúde/Vila Real:Centro Hospitalar investe 90 milhões de euros em ... - Expresso PDF Print

... que albergará as especialidade de pneumologia, pediatria, neurologia, nefrologia (com um serviço de diálise novo) e mais uma área de internamento de ...

read more

 
Business Calendar - The Tennessean PDF Print

17, Nashville Chamber of Commerce, 211 Commerce St., Suite 100. This e-mail address is being protected from spambots. You need JavaScript enabled to view it . Cost: free. Page2radio "Get Connected" social networking event, ...

read more

 
Akela Pharma to cut costs to sustain long-term viability of the ... - Canada NewsWire (press release) PDF Print

Akela's pipeline also includes a growth hormone releasing hormone (GHRH), which is being developed for frailty and wasting in chronic renal disease. ...

read more

 
Dax etwas schwächer erwartet - Financial Times Deutschland PDF Print

von Jörgen Naskrent Aufgrund uneinheitlicher Vorgaben aus Übersee wird der deutsche Aktienmarkt zum Wochenstart leicht im Minus starten. ...

read more

 
Akela Pharma to cut costs to sustain long-term viability of the company (CNW Group via Yahoo! Finance) PDF Print

Akela Pharma Inc. , a drug development company focused on developing an inhaled fentanyl product for breakthrough cancer pain and a growth hormone releasing hormone for chronic renal disease, today announced it will be implementing measures to cut costs in order to preserve cash for its continued operations.

read more

 
<< Start < Prev 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 Next > End >>

Page 2170 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.